press release – price-sensitive

SHAREHOLDERS’ MEETING OF ARTERRA BIOSCIENCE S.P.A.

FINANCING AND GRANTING OF FUNDING FOR THE ‘RE-FOOD’ PROJECT IN THE AMOUNT OF €720,000

PUBLICATION OF NOTICE OF CALL FOR ORDINARY SHAREHOLDERS’ MEETING

THE BOARD OF DIRECTORS HAS APPROVED THE DRAFT FINANCIAL STATEMENTS AS OF 31 DECEMBER 2025

TURNOVER AS OF 31 DECEMBER 2025 AMOUNTING TO €4.6 MILLION, AN INCREASE OF 11.42% COMPARED TO THE SAME PERIOD IN 2024

TRANSFER OF SHARES BY MARIA GABRIELLA COLUCCI TO SMART CAPITAL

ARTERRA BIOSCIENCE S.P.A.: TURNOVER AT SEPTEMBER 30, 2025, APPROXIMATELY 3.6 MILLION EUROS

ARTERRA BIOSCIENCE ANNOUNCES THE SIGNING OF THE ADDENDUM TO THE VITALAB SHAREHOLDERS’ AGREEMENT

THE BOARD OF DIRECTORS HAS APPROVED THE HALF-YEARLY REPORT AS OF 30 JUNE 2025

SUBSTANTIAL CHANGE IN OWNERSHIP STRUCTURE